FSD Pharma Generates $7.7 Million in Proceeds and 670% Return on Investment through Sale of Interest in Cannara Biotech
![C.HUGE, FSD Pharma, cannabis, pot](https://i0.wp.com/motherlodetv.net/wp-content/uploads/2018/07/HUGE-logo-140.jpg?fit=140%2C75&ssl=1)
![](https://i0.wp.com/rt.newswire.ca/rt.gif?w=570&ssl=1)
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced the sale of its 12% equity interest in Cannara Biotech Inc. (CSE: LOVE) (“Cannara”) to a consortium of buyers for cash proceeds of more than $7.7 million (the “Share Sale Transaction”).